Land: Australia
Språk: engelsk
Kilde: Department of Health (Therapeutic Goods Administration)
latanoprost, Quantity: 50 microgram/mL; timolol maleate, Quantity: 5 mg/mL
Arrotex Pharmaceuticals Pty Ltd
Latanoprost,Timolol maleate
Eye Drops, solution
Excipient Ingredients: monobasic sodium phosphate monohydrate; benzalkonium chloride; water for injections; dibasic sodium phosphate; hydrochloric acid; sodium chloride; sodium hydroxide
Ophthalmic
2.5 mL (in 5 mL bottle)
(S4) Prescription Only Medicine
Reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. Latanoprost/Timolol eye drops should not be used to initiate therapy.
Visual Identification: Clear colourless solution, white translucent LDPE bottle, with white translucent LDPE dropper, light yellow opaque HDPE cap with sealing tape; Container Type: Bottle; Container Material: LDPE; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius
Registered
2014-04-08